by Tara Fernandez | Oct 17, 2019
RNA-based vaccines have been heralded as a new molecular weapon in the arsenal against cancer and infections. Five years ago, they were thrust into the spotlight following a $52 million investment by the Bill and Melinda Gates Foundation to CureVac, a...
by Stacey Johnson | Aug 11, 2017
Whenever something sounds too good to be true, it usually is. The expression is used widely in a variety of contexts, one of which is as a warning to avoid being taken in by a scam or taken advantage of. Unfortunately, it applies to the stem cell field too. I am...
by Hamideh Emrani | Aug 10, 2015
. In her series “What drives research in the field of biomaterials?” blogger Hamideh Emrani interviews a third highly respected biomaterials researcher. You can read her interviews with Professors John Davies and Craig Simmons (University of Toronto) here and here. My...
by Angela C. H. McDonald | Aug 13, 2012
It takes precision, focus and persistence to perfect the art of origami. So perhaps it is no accident that researchers have needed to apply the same skills to overcome challenges in siRNA delivery, right down to the folding. A couple of years ago, my fellow blogger...
by Angela C. H. McDonald | May 29, 2012
Nanotechnology has been a buzzword in the medical technology community for some time. It is defined as the manipulation and use of microscopic structures at the molecular scale, generally 1-100 nanometres in size (1 nanometre is 1 billionth of a metre, which...
Comments